Mevsimsel Alerjik Konjonktivitli Çocuklarda Sistemik İnflamasyon Biyobelirteçlerinin İncelenmesi

Amaç: Oküler alerjinin en sık formu olan mevsimsel alerjik konjonktivit ağırlıklı olarak genç popülasyonu etkilemesive son yıllarda artan insidansı nedeniyle dikkat çekmeye devam etmektedir. Daha çok lokal inflamatuar bir konjonktivahastalığı olduğu düşünülen bu rahatsızlığın sistemik kökenleri belirsizdir. Bu çalışmada mevsimsel alerjik konjonktivitliçocuklarda tam kan sayımı parametreleri ve kan temelli sistemik inflamasyon biyobelirteçlerinin düzeylerininincelenmesi amaçlanmıştır.Gereç ve Yöntemler: Mevsimsel alerjik konjonktivit dışında herhangi bir oküler ya da sistemik hastalığı olmayan 26çocuk hasta ve yaş-cinsiyet uyumlu 31 sağlıklı gönüllü çalışmaya dahil edildi. Retrospektif olarak olguların son bir ayiçindeki hemogram sonuçlarına bakılarak nötrofil sayı/yüzdesi, lenfosit sayı/yüzdesi, hemoglobin, eritrosit sayısı,lökosit sayısı, ortalama trombosit hacmi, eritrosit dağılım genişliği ve trombosit sayıları belirlendi ve nötrofil/lenfositoranı, trombosit/lenfosit oranı, sistemik immün-inflamasyon indeksi hesaplandı. İstatistiksel değerlendirmede ki-karetesti, bağımsız örneklemler t-testi ve Mann-Whitney U testi kullanıldı.Bulgular: Gruplar arasında lökosit, eritrosit, trombosit sayı ve yüzdelerinin benzer olduğu görüldü. Hemoglobin,eritrosit dağılım genişliği ve ortalama trombosit hacmi açısından da anlamlı fark saptanmadı. Nötrofil/lenfosit oranı,trombosit/lenfosit oranı ve sistemik immün-inflamasyon indeksi oranları da benzerdi (sırasıyla P=0,848 P=0,276 veP=0,701).Sonuç: Mevsimsel alerjik konjonktivitli çocuklarda kan temelli sistemik inflamasyon biyobelirteçlerinin düzeylerindeanlamlı farklılık görülmemiştir. Bu hastalığın sistemik inflamatuar temeline yönelik daha geniş çaplı araştırmalargereklidir.

Investigation of Systemic Inflammation Biomarkers in Children with Seasonal Allergic Conjunctivitis

Aim: Seasonal allergic conjunctivitis, the most frequent form of ocular allergy, keeps drawing attention as it predominantly affects the young population and its incidence rate increases recently. The systemic origins of this disorder, which is thought to be a more local inflammatory conjunctival disease, are uncertain. In this study, we aimed to examine the complete blood count parameters and blood-based systemic inflammatory markers in children with seasonal allergic conjunctivitis. Materials and Methods: 26 children with no ocular or systemic disease apart from seasonal allergic conjunctivitis and 31 age and sex-matched healthy volunteers were included in the study. Retrospectively, by recording the complete blood count for previous month, neutrophil count/percentage, lymphocyte count/percentage, hemoglobin, red blood cell count, white blood cell count, mean platelet volume, red cell distribution width and platelet count were determined and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index were calculated. Chisquare test, independent samples t-test and Mann-Whitney U test were used for statistical evaluation. Results: The number and percentage of leukocytes, erythrocytes, platelets were observed to be similar in groups. There was no significant difference in terms of hemoglobin, erythrocyte distribution width and mean platelet volume as well.Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index were also similar (P=0.848 P=0.276 and P=0.701 respectively). Conclusion: No significant difference was observed in the level of blood-based systemic inflammatory biomarkers in children with seasonal allergic conjunctivitis. Further research is required to explore the systemic inflammatory basis of this disease.

PDF

___

1. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr. 2013; 39: 18.
2. Miyazaki D, Fukagawa K, Fukushima A, Fujishima H, Uchio E, Ebihara N, et al. Air pollution significantly associated with severe ocular allergic inflammatory diseases. Sci Rep. 2019; 9(1): 18205.
3. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol. 1992; 89(1 Pt 1): 1–15.
4. Kanski JJ. Clinical ophthalmology: a systematic approach. 6th ed. Philadelphia, PA, Pennsylvania: Butterworth- Heinemann; 2007.
5. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye (Lond). 2004: 18(4): 345– 51.
6. Bremond-Gignac D, Donadieu J, Leonardi A, Pouliquen P, Doan S, Chiambarretta F, et al. Prevalence of vernal keratoconjunctivitis: a rare disease?. Br J Ophthalmol. 2008; 92(8): 1097–102.
7. Schröder K, Finis D, Meller S, Wagenmann M, Geerling G, Pleyer U. Seasonal allergic conjunctivitis. Ophthalmologe. 2017; 114(11): 1053-65.
8. Leonardi A, Castegnaro A, Valerio AL, Lazzarini D. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a populationbased study. Curr Opin Allergy Clin Immunol. 2015; 15(5): 482-8.
9. Mehta R. Allergy and asthma: allergic rhinitis and allergic conjunctivitis. FP Essent. 2018; 472: 11-5.
10. Sánchez-Hernández MC, Montero J, Rondon C, Benitez del Castillo JM, Velázquez E, Herreras JM, et al (SEAIC 2010 Rhinoconjunctivitis Committee; Spanish Group Ocular Surface-GESOC). Consensus document on allergic conjunctivitis (DECA). J Investig Allergol Clin Immunol. 2015; 25(2): 94-106.
11. Akçam H. Konjonktival pterjium etyopatogenezinde sistemik inflamasyonun rolünün değerlendirilmesi. DÜ Sağlık Bil Enst Derg. 2019; 9(3): 145-9.
12. Singh K, Bielory L, Hackensack NJ, Newark NJ. Epidemiology of ocular allergy symptoms in United States adults (1988-1994). Ann Allergy Asthma Immunol. 2007; 98(A22): 34.
13. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P, Weiland SK, et al. Are asthma and allergies in children and adolescents increasing?: results from ISAAC phase I and phase III surveys in Munster, Germany. Allergy. 2003; 58(7): 572–9.
14. Sacchetti M, Abicca I, Bruscolini A, Cavaliere C, Nebbioso M, Lambiase A. Allergic conjunctivitis: current concepts on pathogenesis and management. J Biol Regul Homeost Agents. 2018; 32(1 Suppl. 1): 49-60.
15. Leonardi S, del Giudice Miraglia M, La Rosa M, Bellanti JA. Atopic disease, immune system, and the environment. Allergy Asthma Proc. 2007; 28(4): 410– 7.
16. Offiah I, Calder VL. Immune mechanisms in allergic eye diseases: what is new?. Curr Opin Allergy Clin Immunol. 2009; 9(5): 477-81.
17.Bielory BP, O'Brien TP, Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmol. 2012; 90(5): 399-407.
18. Wong AH, Barg SS, Leung AK. Seasonal and perennial conjunctivitis. Recent Pat Inflamm Allergy Drug Discov. 2009; 3(2): 118–27.
19.Jo-Watanabe A, Okuno T, Yokomizo T. The role of leukotrienes as potential therapeutic targets in allergic disorders. Int J Mol Sci. 2019; 20(14): pii-E3580.
20. Friedlander MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011; 11(5): 477-82.
21. Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol. 2007; 7(5): 429–35.
22. Saban DR, Calder V, Kuo CH, Reyes NJ, Dartt DA, Ono SJ, et al. New twists to an old story: novel concepts in the pathogenesis of allergic eye disease. Curr Eye Res. 2013; 38(3): 317-30.
23. Dadaci Z, Oncel M, Oncel Acir N, Sahin E, Borazan M. Oxidative stress parameters and serum magnesium levels in patients with seasonal allergic conjunctivitis. Cutan Ocul Toxicol. 2016; 35(4): 270-4.
24. Elbey B, Yazgan ÜC, Yıldırım A, Karaalp Ü, Şahin A. Vernal keratokonjonktivitli olgularda ortalama trombosit hacmi ve nötrofil/lenfosit oranı. J Clin Exp Invest. 2015; 6(1): 40-5.
25. Shetty R, Sureka S, Kusumgar P, Sethu S, Sainani K. Allergen-specific exposure associated with high immunoglobulin E and eye rubbing predisposes to progression of keratoconus. Indian J Ophthalmol. 2017; 65(5): 399-402.
26. Sacchetti M, Bruscolini A, Lambiase A. Neurotrophic factors and nerve growth factor in ocular allergy. Curr Opin Allergy Clin Immunol. 2019; 19(5): 510-6.
27.Chung SH, Chang SY, Lee HJ, Choi SH. The C-C chemokine receptor 6 (CCR6) is crucial for Th2- driven allergic conjunctivitis. Clin Immunol. 2015; 161(2): 110-9.
28. Yuksel H, Yilmaz O, Sogut A, Ertan P, Onur E. Correlation of quality of life with clinical parameters and eosinophilic cation protein levels in children with allergic rhinoconjunctivitis. Int Arch Allergy Immunol. 2009; 148(1): 18-22.
29. Uchio E, Ono S, Ikezawa Z, Ohno S. Serum levels of soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis. Allergy. 1999; 54(2): 135-41.
30. Lambiase A, Bonini S, Micera A, Tirassa P, Magrini L, Bonini S, et al. Increased plasma levels of substance P in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1997; 38(10): 2161-4.
31. Faria SS, Fernandes PC Jr, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, et al. The neutrophil-tolymphocyte ratio: a narrative review. Ecancermedicalscience. 2016; 10: 702.
32. Fankhauser CD, Sander S, Roth L, Gross O, Eberli D, Sulser T, et al. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer. 2018; 118(6): 825-30.